Markers of T Lymphocyte Activation in HLA-B8, DR3 Positive Individuals
- 30 November 1990
- journal article
- Published by Elsevier in Immunobiology
- Vol. 181 (4-5) , 257-266
- https://doi.org/10.1016/s0171-2985(11)80517-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetesPublished by Elsevier ,2004
- HLA‐B8,DR3 PHENOTYPE AND LYMPHOCYTE RESPONSES TO PHYTOHAEMAGGLUTININInternational Journal of Immunogenetics, 1990
- Soluble Interleukin-2 Receptor Secretion Defectin Vitroin HLA-B8, DR3 Positive SubjectsAutoimmunity, 1990
- OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressionsClinical Immunology and Immunopathology, 1988
- LymphokinesNew England Journal of Medicine, 1987
- HLA-DR-linked genes are involved in the control of T lymphocyte blood levelsClinical Immunology and Immunopathology, 1987
- A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?Clinical Immunology and Immunopathology, 1987
- Immune abnormalities associated with HLA-B8: Lymphocyte subsets and functional correlatesClinical Immunology and Immunopathology, 1986
- Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosusClinical Immunology and Immunopathology, 1984
- Surface antigens specifically expressed by activated T cells in humansEuropean Journal of Immunology, 1981